Incyte: JP Morgan raises target price to $120 from $110
INCY•Related News
Gaxos swings to GAAP net income of $241,056 in Q2 FY26; revenue rises 35.8% sequentially to $2.46 million
GXAI•
OTG Acquisition Q2 FY26 net income rises to $1.73 million
OTGA•
Acrivon Q2 FY26 net loss narrows 14.48% to $18 million
ACRV•
Intapp CEO John T. Hall disposes of 3,000 common shares for $111,120
INTA•
Kura Oncology Q2 product revenue rises 57% on KOMZIFTI uptake
KURA•